Piramed

Showing 3 posts of 3 posts found.

Michael Moore, chairman, Oxford BioTherapeutics

January 11, 2010
Research and Development Oxford Biotherapeutics, Piramed, appointment, research and development

Oxford BioTherapeutics (OBT) has appointed Dr Michael Moore non-executive chairman. He joins the company following five years spent at UK …

Roche to buy Piramed

April 15, 2008
Sales and Marketing MA, Piramed

 Roche is set to pay $160 million (£315 million) to buy UK biotech company Piramed, a move which will further …

Piramed and Domainex named among best of British biotech

July 12, 2007
Research and Development Piramed, domainex

Piramed and Domainex are among the cutting-edge companies which have been recognised as the best of the UKs biotech sector.UK …

Latest content